• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿肌酐代谢物谱作为神经发育障碍的筛查试验。

Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.

机构信息

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, USA.

Metabolic Laboratory, Department of Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, USA.

出版信息

Orphanet J Rare Dis. 2020 Dec 2;15(1):339. doi: 10.1186/s13023-020-01617-z.

DOI:10.1186/s13023-020-01617-z
PMID:33267903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709238/
Abstract

BACKGROUND

Cerebral creatine deficiency disorders (CCDD) are inherited metabolic disorders of creatine synthesis and transport. Urine creatine metabolite panel is helpful to identify these disorders.

METHODS

We reviewed electronic patient charts for all patients that underwent urine creatine metabolite panel testing in the metabolic laboratory at our institution.

RESULTS

There were 498 tests conducted on 413 patients. Clinical, molecular genetics and neuroimaging features were available in 318 patients. Two new patients were diagnosed with creatine transporter deficiency: one female and one male, both had markedly elevated urine creatine. Urine creatine metabolite panel was also used as a monitoring test in our metabolic laboratory. Diagnostic yield of urine creatine metabolite panel was 0.67% (2/297). There were six known patients with creatine transporter deficiency. The prevalence of creatine transporter deficiency was 2.64% in our study in patients with neurodevelopmental disorders who underwent screening or monitoring of CCDS at our institution.

CONCLUSION

Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD. To the best of our knowledge, this study is the first Canadian study to report diagnostic yield of urine creatine metabolite panel for CCDD from a single center.

摘要

背景

脑肌酸缺乏症(CCDD)是肌酸合成和转运的遗传性代谢紊乱。尿肌酸代谢物谱有助于识别这些疾病。

方法

我们回顾了我院代谢实验室进行尿肌酸代谢物谱检测的所有患者的电子病历。

结果

共对 413 名患者进行了 498 次检测,318 名患者具有临床、分子遗传学和神经影像学特征。两名新患者被诊断为肌酸转运蛋白缺乏症:一名女性和一名男性,两者的尿肌酸均明显升高。尿肌酸代谢物谱也被用作我们代谢实验室的监测试验。尿肌酸代谢物谱的诊断率为 0.67%(2/297)。有 6 名已知的肌酸转运蛋白缺乏症患者。在我们的研究中,对在我院接受 CCDS 筛查或监测的神经发育障碍患者进行分析,肌酸转运蛋白缺乏症的患病率为 2.64%。

结论

尽管尿肌酸代谢物谱的诊断率较低,但它可以成功检测到 CCDD 患者,尽管许多神经发育障碍并非 CCDD 所致。据我们所知,这是来自单一中心的针对 CCDD 的尿肌酸代谢物谱的首次加拿大研究报告诊断率。

相似文献

1
Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.尿肌酐代谢物谱作为神经发育障碍的筛查试验。
Orphanet J Rare Dis. 2020 Dec 2;15(1):339. doi: 10.1186/s13023-020-01617-z.
2
Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.脑肌酸缺乏症-来自印度的临床、遗传和随访研究。
Brain Dev. 2022 Apr;44(4):271-280. doi: 10.1016/j.braindev.2021.12.004. Epub 2021 Dec 30.
3
Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes.脑肌酸缺乏综合征患者的生化、分子和临床诊断。
Mol Genet Metab. 2013 Jul;109(3):260-8. doi: 10.1016/j.ymgme.2013.04.006. Epub 2013 Apr 17.
4
Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.脑肌酸缺乏症:一组可治疗的智力发育障碍
Semin Neurol. 2014 Jul;34(3):350-6. doi: 10.1055/s-0034-1386772. Epub 2014 Sep 5.
5
Primary creatine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure: case presentation with two novel variants and literature review.原发性肌酸缺乏症在精神运动发育迟缓伴发癫痫的儿童中可能被漏诊:伴有两种新变异型的病例报告及文献复习
Acta Neurol Belg. 2020 Jun;120(3):511-516. doi: 10.1007/s13760-019-01168-6. Epub 2019 Jun 20.
6
[Cerebral creatine deficiency syndromes].[脑肌酸缺乏综合征]
Acta Med Port. 2012 Nov-Dec;25(6):389-98. Epub 2013 Jan 28.
7
Creatine Transporter Deficiency Presenting as Failure to Thrive: A Case Report of a Novel Variant Causing a Treatable but Likely Underdiagnosed Genetic Disorder.肌酸转运蛋白缺乏症表现为生长不良:一种新型变异导致的可治疗但可能被低估的遗传疾病病例报告。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231154438. doi: 10.1177/23247096231154438.
8
Disorders of creatine transport and metabolism.肌酸转运和代谢障碍。
Am J Med Genet C Semin Med Genet. 2011 Feb 15;157C(1):72-8. doi: 10.1002/ajmg.c.30292. Epub 2011 Feb 9.
9
Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes.脑肌酸缺乏综合征的诊断方法与建议
Pediatr Res. 2015 Mar;77(3):398-405. doi: 10.1038/pr.2014.203. Epub 2014 Dec 18.
10
Creatine biosynthesis and transport in health and disease.健康与疾病状态下的肌酸生物合成及转运
Biochimie. 2015 Dec;119:146-65. doi: 10.1016/j.biochi.2015.10.022. Epub 2015 Nov 2.

引用本文的文献

1
How a patient-led advocacy organization supports the road to diagnosis and treatment of creatine transporter deficiency.一个由患者主导的倡导组织如何支持肌酸转运体缺乏症的诊断和治疗之路。
Front Neurosci. 2025 Feb 25;19:1548182. doi: 10.3389/fnins.2025.1548182. eCollection 2025.
2
Creatine transporter (SLC6A8) knockout mice exhibit reduced muscle performance, disrupted mitochondrial Ca homeostasis, and severe muscle atrophy.肌酸转运蛋白(SLC6A8)基因敲除小鼠表现出肌肉性能下降、线粒体钙稳态破坏和严重的肌肉萎缩。
Cell Death Dis. 2025 Feb 14;16(1):99. doi: 10.1038/s41419-025-07381-x.
3
Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).

本文引用的文献

1
Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy.靶向下一代测序 panels 和全外显子组测序在儿童癫痫中的临床应用。
Neuroscience. 2019 Oct 15;418:291-310. doi: 10.1016/j.neuroscience.2019.08.016. Epub 2019 Sep 2.
2
Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study.二十二例胍基乙酸甲基转移酶缺陷症患者的治疗结果:一项国际回顾性队列研究。
Eur J Paediatr Neurol. 2018 May;22(3):369-379. doi: 10.1016/j.ejpn.2018.02.007. Epub 2018 Feb 16.
3
Treatment outcome of creatine transporter deficiency: international retrospective cohort study.
神经发育障碍的遗传和代谢研究:加拿大医学遗传学家学院(CCMG)的立场声明。
J Med Genet. 2023 Jun;60(6):523-532. doi: 10.1136/jmg-2022-108962. Epub 2023 Feb 23.
4
Creatine Transporter Deficiency Presenting as Failure to Thrive: A Case Report of a Novel Variant Causing a Treatable but Likely Underdiagnosed Genetic Disorder.肌酸转运蛋白缺乏症表现为生长不良:一种新型变异导致的可治疗但可能被低估的遗传疾病病例报告。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231154438. doi: 10.1177/23247096231154438.
5
Diagnostic Process for Autism Spectrum Disorder: A Meta-Analysis of Worldwide Clinical Practice Guidelines for the Initial Somatic Assessment.孤独症谱系障碍的诊断流程:对全球初始躯体评估临床实践指南的荟萃分析
Children (Basel). 2022 Dec 1;9(12):1886. doi: 10.3390/children9121886.
6
Laboratory Diagnosis of Cerebral Creatine Deficiency Syndromes by Determining Creatine and Guanidinoacetate in Plasma and Urine.通过测定血浆和尿液中的肌酸和胍乙酸对脑肌酸缺乏综合征进行实验室诊断。
Methods Mol Biol. 2022;2546:129-140. doi: 10.1007/978-1-0716-2565-1_12.
7
Case report: Clinical and magnetic resonance spectroscopy presentation of a female severely affected with X-linked creatine transporter deficiency.病例报告:一名严重受X连锁肌酸转运体缺乏症影响的女性患者的临床及磁共振波谱表现
Radiol Case Rep. 2022 Feb 3;17(4):1115-1119. doi: 10.1016/j.radcr.2022.01.053. eCollection 2022 Apr.
肌酸转运蛋白缺乏症的治疗结果:国际回顾性队列研究。
Metab Brain Dis. 2018 Jun;33(3):875-884. doi: 10.1007/s11011-018-0197-3. Epub 2018 Feb 12.
4
The role of dietary creatine.膳食肌酸的作用。
Amino Acids. 2016 Aug;48(8):1785-91. doi: 10.1007/s00726-016-2188-1. Epub 2016 Feb 13.
5
Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide.精氨酸:甘氨酸脒基转移酶(AGAT)缺乏症:全球确诊的16例患者的临床特征及长期预后
Mol Genet Metab. 2015 Dec;116(4):252-9. doi: 10.1016/j.ymgme.2015.10.003. Epub 2015 Oct 17.
6
Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency.新生儿干血斑中胍基乙酸盐的升高及其对 GAMT 缺乏症早期治疗的影响。
Mol Genet Metab. 2013 Jun;109(2):215-7. doi: 10.1016/j.ymgme.2013.03.003. Epub 2013 Mar 16.
7
Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine.了解吡咯啉-5-羧酸合成酶缺乏症:临床、分子、功能和表达研究、基于结构的分析以及精氨酸的新疗法。
J Inherit Metab Dis. 2012 Sep;35(5):761-76. doi: 10.1007/s10545-011-9411-8. Epub 2011 Dec 15.
8
Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by un-derivatized liquid chromatography-tandem mass spectrometry.采用未衍生化液相色谱-串联质谱法同时测定尿液和血浆中的胍基乙酸、肌酸和肌酐。
Ann Clin Biochem. 2008 Nov;45(Pt 6):575-84. doi: 10.1258/acb.2008.008029. Epub 2008 Sep 9.
9
Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency.新生儿胍基乙酸甲基转移酶缺乏症的症状前治疗。
Neurology. 2006 Aug 22;67(4):719-21. doi: 10.1212/01.wnl.0000230152.25203.01.
10
High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: implications for treatment?精氨酸琥珀酸合成酶和裂解酶缺乏症中脑胍乙酸水平升高及肌酸浓度变化:对治疗有何启示?
Mol Genet Metab. 2006 Nov;89(3):274-6. doi: 10.1016/j.ymgme.2006.02.005. Epub 2006 Apr 3.